Cancers are still a major public health issue. Promoting innovation in oncology in France therefore remains a priority.

AstraZeneca demonstrates an ongoing commitment to eliminating cancer as a cause of death. The In’CaRe call for projects aims to promote cancer research and improve the care pathway for patients with cancer or hematological malignancies.

The In’CaRe call for projects aims to support projects and initiatives that will be of major interest in oncology and/or hematology. For each winning project, AstraZeneca will provide financial support of up to €160,000 to help set up and/or develop these projects.

End of receipt of application files: September 29, 2023

More info: HERE.

To submit your application: HERE.